Liner Hanger Market Share

  • Report ID: 5040
  • Published Date: Feb 25, 2026
  • Report Format: PDF, PPT

Liner Hanger Market - Regional Analysis

North American Market Insights

North America industry is predicted to dominate majority revenue share of 35% by 2035, owing to the large consumption of petroleum and petroleum products. As per U.S. Energy Information Administration, the country has averagely utilized around 19.89 million barrels of petroleum each day.  Also, the high demand for energy by the American population is another growth factor of the market in the region owing to its usage in the drilling process.

APAC Market Insights

The Asia Pacific liner hanger market is set to hold 24% of the revenue share by the end of the projected timeframe. Asia Pacific is expected to observe a growth outlook in the coming years owing to the need to bridge the gap between the demand and supply of oil and oil products. In addition, the expanding oil and gas industries in China and India are also expected to propel the expansion of the market.

Liner Hanger

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of liner hanger is assessed at USD 106.8 billion.

The global liner hanger market size was valued at more than USD 101.24 billion in 2025 and is expected to register a CAGR of over 6.1%, exceeding USD 183.02 billion revenue by 2035.

North America is projected to dominate the market with a 35% revenue share by 2035, driven by high petroleum consumption and growing energy demand for drilling activities.

Key players in the market include AstraZeneca PLC, Eisai Co., Ltd., GSK plc., Takeda Pharmaceutical Company Limited., Ironwood Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., SFJ Pharmaceuticals, Sebela Pharmaceuticals, Phathom Pharmaceuticals, Inc., Camber Pharmaceuticals, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos